Login
From:
Parkinson's News Today
(Uncensored)
subscribe
Target enrollment complete in Phase 1b trial of GT-02287
https://parkinsonsnewstoday.com/news/target-enrollment-complete-phase-1b-trial-gt-02287/
links
backlinks
Tagged with:
news
clinical trial
gt-02287
Target enrollment is complete for a Phase 1b trial testing the safety and tolerability of GT-02287 in people with Parkinson’s disease.
Roast topics
Find topics
Find it!
